Jounce Therapeutics to Present at Upcoming Investor Conferences in September
29 août 2018 08h00 HE
|
Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and...
VBI Vaccines to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
28 août 2018 08h00 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ:VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
Galectin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
02 avr. 2018 10h20 HE
|
Galectin Therapeutics Inc.
NORCROSS, Ga., April 02, 2018 (GLOBE NEWSWIRE) --
Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that...